68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series

Gallium-68 fibroblast activation protein inhibitor (68Ga-FAPI) PET/CT targets cancer-associated fibroblasts and may provide complementary information in challenging thyroid cancer cases. We retrospectively evaluated seven patients with thyroid cancer who underwent 68Ga-FAPI-04 PET/CT between November 2023 and December 2025 for suspected recurrent or metastatic disease or further characterization of known disease. The cohort comprised three males and four females (median age, 39 years; range, 20–81 years) with follicular cell-derived or medullary thyroid carcinoma. Findings were compared descriptively with available anatomical imaging, radioiodine scintigraphy, 18F-FDG PET/CT, and 68Ga-DOTATATE PET/CT. Histopathology and clinical or imaging follow-up were used for lesion characterization where available. FAPI uptake varied substantially, ranging from low uptake in histologically confirmed metastatic follicular thyroid carcinoma (SUVmax 1.5) to intense uptake in a gluteal lesion (early/delayed SUVmax 17.7/32.6) that subsequently regressed metabolically, favoring an inflammatory process. FAPI provided additional lesion characterization in medullary thyroid carcinoma, although a newly identified parapharyngeal lesion remained unconfirmed, and the muscular focus was indeterminate. Discordance with FDG and DOTATATE findings was also observed. 68Ga-FAPI PET/CT may provide complementary information in selected thyroid cancer cases but requires cautious interpretation alongside other imaging, histopathology, and follow-up.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-20
DOI
https://doi.org/10.3390/ijms272210466
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series

Diyaa Juaidi, Marwah Abdulrahman, Akram Al‐Ibraheem, Saad Ruzzeh et al.
2 links
International Journal of Molecular Sciences
Thyroid Cancer Diagnosis and Treatment
article

68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series

Diyaa Juaidi, Marwah Abdulrahman, Akram Al‐Ibraheem, Saad Ruzzeh, Nouraldeen Alzorgan, Tasneem Alkahder, Noor Abdul Malek, Hussam Haddad, Maryam Muthanna, Soud Al-Qasem
article en

Abstract

Gallium-68 fibroblast activation protein inhibitor (68Ga-FAPI) PET/CT targets cancer-associated fibroblasts and may provide complementary information in challenging thyroid cancer cases. We retrospectively evaluated seven patients with thyroid cancer who underwent 68Ga-FAPI-04 PET/CT between November 2023 and December 2025 for suspected recurrent or metastatic disease or further characterization of known disease. The cohort comprised three males and four females (median age, 39 years; range, 20–81 years) with follicular cell-derived or medullary thyroid carcinoma. Findings were compared descriptively with available anatomical imaging, radioiodine scintigraphy, 18F-FDG PET/CT, and 68Ga-DOTATATE PET/CT. Histopathology and clinical or imaging follow-up were used for lesion characterization where available. FAPI uptake varied substantially, ranging from low uptake in histologically confirmed metastatic follicular thyroid carcinoma (SUVmax 1.5) to intense uptake in a gluteal lesion (early/delayed SUVmax 17.7/32.6) that subsequently regressed metabolically, favoring an inflammatory process. FAPI provided additional lesion characterization in medullary thyroid carcinoma, although a newly identified parapharyngeal lesion remained unconfirmed, and the muscular focus was indeterminate. Discordance with FDG and DOTATATE findings was also observed. 68Ga-FAPI PET/CT may provide complementary information in selected thyroid cancer cases but requires cautious interpretation alongside other imaging, histopathology, and follow-up.

International Journal of Molecular SciencesVol. 27(22)
University of Jordan (JO), King Hussein Cancer Center (JO)
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon